ZS Pharma (ZSPH) Posts Q3 Loss of 41c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts ZSPH Hot Sheet
Join SI Premium – FREE
ZS Pharma (Nasdaq: ZSPH) reported Q3 EPS of ($0.41), $0.63 better than the analyst estimate of ($1.04).
The company reported a loss of $0.81 per share in the same period last year.
For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
- Goldman Sachs Upgrades Technip Energies NV (TE:FP) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
